Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis (clinicaltrials.gov) - Sep 16, 2026 - P2 | N=20 | Recruiting | Sponsor: Chinese PLA General Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • ANCA Vasculitis • Glomerulonephritis • Nephrology • Vasculitis
|